DEPOMED INC's ticker is and the CUSIP is 249908AA2. A total of 43 filers reported holding DEPOMED INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $14,984,000 | +1.2% | 20,668,000 | +3.3% | 0.00% | 0.0% |
| Q3 2019 | $14,808,000 | +4.3% | 20,011,000 | +0.9% | 0.00% | 0.0% |
| Q2 2019 | $14,200,000 | -8.0% | 19,841,000 | -1.4% | 0.00% | -20.0% |
| Q1 2019 | $15,435,000 | +1.8% | 20,126,000 | -10.7% | 0.01% | 0.0% |
| Q4 2018 | $15,168,000 | +21.5% | 22,535,000 | +47.5% | 0.01% | +25.0% |
| Q2 2018 | $12,483,000 | +7.8% | 15,281,000 | +7.0% | 0.00% | +33.3% |
| Q1 2018 | $11,579,000 | +4.2% | 14,281,000 | +8.5% | 0.00% | 0.0% |
| Q4 2017 | $11,111,000 | +7.8% | 13,158,000 | -5.9% | 0.00% | 0.0% |
| Q3 2017 | $10,309,000 | -2.4% | 13,989,000 | +16.2% | 0.00% | 0.0% |
| Q2 2017 | $10,565,000 | -40.1% | 12,039,000 | -36.3% | 0.00% | -50.0% |
| Q1 2017 | $17,642,000 | +158.0% | 18,893,000 | +214.6% | 0.01% | +200.0% |
| Q4 2016 | $6,838,000 | -40.6% | 6,005,000 | -25.8% | 0.00% | -50.0% |
| Q3 2016 | $11,516,000 | +1.8% | 8,088,000 | -13.8% | 0.00% | 0.0% |
| Q2 2016 | $11,317,000 | -26.9% | 9,378,000 | -43.4% | 0.00% | -33.3% |
| Q1 2016 | $15,486,000 | -0.3% | 16,573,000 | +21.3% | 0.01% | 0.0% |
| Q4 2015 | $15,536,000 | +50.3% | 13,658,000 | +58.1% | 0.01% | +50.0% |
| Q3 2015 | $10,340,000 | +1.3% | 8,638,000 | +8.5% | 0.00% | 0.0% |
| Q2 2015 | $10,203,000 | -65.4% | 7,962,000 | -64.3% | 0.00% | -33.3% |
| Q1 2015 | $29,498,000 | +421.3% | 22,314,000 | +325.7% | 0.01% | +200.0% |
| Q4 2014 | $5,659,000 | +340.4% | 5,242,000 | +331.4% | 0.00% | +100.0% |
| Q3 2014 | $1,285,000 | – | 1,215,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|